These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2954453)

  • 1. A symposium: Doxazosin: coronary artery disease risk factor management. June 7, 1986, Frankfurt, Germany.
    Am J Cardiol; 1987 May; 59(14):1G-104G. PubMed ID: 2954453
    [No Abstract]   [Full Text] [Related]  

  • 2. Doxazosin: A distinctive approach to risk reduction of coronary heart disease in hypertensive patients. Proceedings of a symposium. Hamburg, West Germany, January 30, 1988.
    Am Heart J; 1988 Dec; 116(6 Pt 2):1707-840. PubMed ID: 2974237
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reduction of coronary risk factors with selective alpha-blockers. International Doxazosin Symposium. Frankfurt/Main, 7 June 1986].
    Fortschr Med Suppl; 1986; 8():1-19. PubMed ID: 2876941
    [No Abstract]   [Full Text] [Related]  

  • 4. Alpha 1-adrenoreceptor blockade in hypertension: pharmacological and clinical profile of doxazosin. Proceedings of an international symposium. Venice, Italy, 14 June 1985.
    Br J Clin Pharmacol; 1986; 21 Suppl 1():1S-92S. PubMed ID: 2939864
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of coronary heart disease risk factors in hypertensive patients: clinical experience with doxazosin. A symposium. London, England, January 26, 1990. Proceedings.
    Am Heart J; 1991 Jan; 121(1 Pt 2):245-406. PubMed ID: 1670742
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha-blockade for hypertension: indifferent past, uncertain future.
    Lancet; 1989 May; 1(8646):1055-6. PubMed ID: 2566006
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of alpha-blockers in the management of hypertension: a practical view.
    McInnes GT
    J Hum Hypertens; 1991 Aug; 5(4):313-6. PubMed ID: 1683406
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical settings for selective alpha-adrenergic receptor inhibition: rationale and management strategies. Proceedings of a symposium. Naples, Florida, October 13 to 16, 1988.
    Am J Med; 1989 Aug; 87(2A):1S-66S. PubMed ID: 2569821
    [No Abstract]   [Full Text] [Related]  

  • 9. Doxazosin for treatment of hypertension.
    Med Lett Drugs Ther; 1991 Feb; 33(838):15-6. PubMed ID: 1825232
    [No Abstract]   [Full Text] [Related]  

  • 10. [Doxazosin and nitrendipine. A double-blind comparative study in patients with mild to moderate hypertension].
    Nechwatal W
    Fortschr Med; 1987 Nov; 105(34):679-82. PubMed ID: 2962918
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypertension, coronary risk and alpha-blockade.
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():1-65. PubMed ID: 1979818
    [No Abstract]   [Full Text] [Related]  

  • 12. [New specialty drugs registered in Austria. Supressin].
    Ganzinger U
    Wien Klin Wochenschr; 1989 Oct; 101(20):714-20. PubMed ID: 2531501
    [No Abstract]   [Full Text] [Related]  

  • 13. Implications of doxazosin therapy on risk of coronary heart disease.
    Hansson L
    Am Heart J; 1988 Dec; 116(6 Pt 2):1832-7. PubMed ID: 2904759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxazosin: alternative antihypertensive treatment.
    Bodansky HJ
    Diabet Med; 1992 Jul; 9(6):583. PubMed ID: 1386565
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacotherapeutic stature of doxazosin and its role in coronary risk reduction.
    Taylor SH
    Am Heart J; 1988 Dec; 116(6 Pt 2):1735-47. PubMed ID: 2904744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparative study of doxazosin and prazosin in the treatment of essential hypertension.
    Fukiyama K; Omae T; Iimura O; Yoshinaga K; Yagi S; Inagaki Y; Ishii M; Kaneko Y; Yamada K; Ijichi H
    Am Heart J; 1991 Jan; 121(1 Pt 2):317-22. PubMed ID: 1824654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drugs for hypertension--variations on old themes.
    Drug Ther Bull; 1991 Mar; 29(6):21-2. PubMed ID: 1834451
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind comparison of doxazosin and enalapril in patients with mild or moderate essential hypertension.
    Wessels F
    Am Heart J; 1991 Jan; 121(1 Pt 2):299-303. PubMed ID: 1824653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of initial antihypertensive therapy: new perspectives on coronary heart disease. Risk factors provide new insights. Proceedings of a symposium. June 28-29, 1985, Oslo, Norway.
    Am J Med; 1986 Feb; 80(2A):1-125. PubMed ID: 3946454
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention and treatment of hypertension and coronary heart disease].
    Mendoza-González C; Rosas M; Estrada CL; Lorenzo JA; Méndez A; Martínez-Reding J; Martínez-Sánchez C; Pastelín G; Férez-Santander SM; Attie F
    Arch Cardiol Mex; 2008; 78 Suppl 2():S2-58-73. PubMed ID: 18938686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.